No abstract available
MeSH terms
-
Aminoglycosides / adverse effects*
-
Aminoglycosides / therapeutic use
-
Antibodies, Monoclonal, Humanized / adverse effects*
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Antineoplastic Agents, Immunological / adverse effects*
-
Antineoplastic Agents, Immunological / therapeutic use
-
Child
-
Fatal Outcome
-
Gemtuzumab
-
Haptoglobins / analysis
-
Hematologic Tests
-
Hemoglobins / analysis
-
Hemolysis / drug effects*
-
Humans
-
Leukemia, Myeloid, Acute / blood*
-
Leukemia, Myeloid, Acute / drug therapy
-
Male
-
Palliative Care
Substances
-
Aminoglycosides
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents, Immunological
-
Haptoglobins
-
Hemoglobins
-
Gemtuzumab